التفاصيل البيبلوغرافية
| العنوان: |
Defining pharmacist activities in ambulatory heart failure clinics: North American survey and modified Delphi study. |
| المؤلفون: |
Beauchesne, Arielle B. M., Koshman, Sheri L., Beavers, Craig J., Gorman, Sean K., Turgeon, Ricky D. |
| المصدر: |
JACCP: Journal of the American College of Clinical Pharmacy; Nov2023, Vol. 6 Issue 11, p1180-1190, 11p |
| مصطلحات موضوعية: |
PHARMACISTS, HEART failure, CANADIANS, MEDICAL practice, LIKERT scale |
| مصطلحات جغرافية: |
NORTH America |
| مستخلص: |
Background: Pharmacists are key members of multidisciplinary heart failure (HF) clinics; however, there is variation in their roles and activities. This study aimed to: (1) define current roles of HF clinic pharmacists and (2) develop a consensus‐based list of key activities for HF clinic pharmacists. Methods: In part 1, we invited Canadian and American HF clinic pharmacists to complete a survey on activities currently performed in the HF clinic. Part 2 consisted of a three‐round modified Delphi study including only Canadian participants to define key activities for ambulatory HF pharmacists among 44 candidates. In each round, participants rated a list of candidate activities based on importance and priority on a 9‐point Likert scale. Consensus was reached for inclusion when ≥75% of participants rated both criteria ≥7, or exclusion when both criteria ≤6. Participants received personal responses alongside aggregate ratings after each round to facilitate attainment of consensus. Results: Eighty‐four pharmacists participated in part 1, and 29 (of 55 invited) participated in part 2 (24 retained for all three rounds). Current pharmacist activities were similar between American and Canadian participants, with an emphasis on patient assessment and clinical activities including modification of HF‐specific pharmacotherapy. The final consensus‐based list included 32 activities, with high priority placed on activities involving optimization of medications for HF and common comorbidities, engaging in shared decision‐making, assessing adherence, reviewing lab tests, and assessing and modifying medications due to pharmacokinetic/pharmacodynamic parameters, which closely mirrored activities in current practice. Conclusion: Current activities of ambulatory HF pharmacists are largely consistent within North America, focusing on patient assessment and HF‐specific pharmacotherapy modification. Our consensus‐based list defined 32 activities integral to the future role of pharmacists in HF clinics, which builds upon activities being currently performed. This provides a framework to standardize and expand the scope of practice for clinical pharmacy services in HF clinics. [ABSTRACT FROM AUTHOR] |
|
Copyright of JACCP: Journal of the American College of Clinical Pharmacy is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
